000024421 000__ 01350cam\a2200433\i\4500 000024421 001__ 24421 000024421 003__ SzGeWIPO 000024421 005__ 20240708162239.0 000024421 008__ 071205s2008 enk|||||r|||| 00| 0 fre d 000024421 035__ $$a(wipo)0 000024421 035__ $$a(OCoLC)1159542385 000024421 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL 000024421 041__ $$aeng 000024421 043__ $$aa-ja--- 000024421 050_4 $$aK1401.A15$$bJ675 000024421 08204 $$a346.048$$222 000024421 084__ $$aGB 137 000024421 1001_ $$aTessensohn, John A.,$$aYamamoto, Shusaku. 000024421 24510 $$aCrystal clear :$$ba landmark pharma patent victory in Japan 000024421 264_1 $$aOxford [England] :$$bOxford University Press,$$c2008. 000024421 300__ $$a1 volume ([5] pages) ;$$c[28] cm. 000024421 336__ $$atext$$btxt$$2rdacontent 000024421 337__ $$aunmediated$$bn$$2rdamedia 000024421 338__ $$avolume$$bnc$$2rdacarrier 000024421 4901_ $$aJournal Of Intellectual Property Law & Practice,$$x1747-1532 ;$$vGB 137 Jul 2008 Vol 3 No 7, pages 473-478 000024421 650_0 $$aIntellectual property. 000024421 650_0 $$aIntangible property. 000024421 650_0 $$aIntellectual property$$zJapan. 000024421 650_0 $$aPatents$$zJapan. 000024421 650_4 $$aPharmaceutical Patents$$zJapan 000024421 650_4 $$aPatent disclosure$$zAustralia 000024421 651_0 $$aJapan$$xCommerce$$xLaw and legislation. 000024421 830_0 $$aJournal Of Intellectual Property Law & Practice ;$$vGB 137 Jul 2008 Vol 3 No 7, pages 473-478. 000024421 8564_ $$uhttp://jiplp.oxfordjournals.org/cgi/reprint/3/7/473$$y[For WIPO staff only] 000024421 903__ $$aJournal of Intellectual Property Law & Practice. 000024421 904__ $$aJournal article 000024421 942__ $$cART$$jGB 137 April 2008 Vol 3 No 4$$2ddc 000024421 952__ $$w2008-06-27$$p2008-0443$$u38093$$bMAIN$$10$$kGB 137$$v2008-06-27$$70$$cMain Library$$yART 000024421 980__ $$aBIB 000024421 999__ $$c26694$$d26694